Incyte Corp. (INCY)
95.93
+1.63
(+1.73%)
USD |
NASDAQ |
Apr 02, 16:00
95.00
-0.93
(-0.97%)
Pre-Market: 20:00
Incyte EPS Diluted (Quarterly) : 1.462 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Merck & Co., Inc. | 1.191 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Bristol Myers Squibb Co. | 0.5326 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 299.28M |
| Revenue (Quarterly) | 1.507B |
| Total Expenses (Quarterly) | 1.208B |
| Enterprise Value | 15.57B |
| Gross Profit Margin (Quarterly) | 90.88% |
| Profit Margin (Quarterly) | 19.86% |
| Earnings Yield | 6.68% |
| Operating Earnings Yield | 6.97% |
| Normalized Earnings Yield | 6.028 |